On February 22, 2022, The E&M Co., Ltd. closed the transaction. The transaction included participation from Hwail Pharmaceutical Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,946 KRW | +6.86% |
|
+2.75% | -3.18% |
05-24 | The E&M Co., Ltd. announced that it has received KRW 1.799998644 billion in funding | CI |
05-16 | The E&M Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-3.18% | 29.97M | |
+29.84% | 449B | |
+37.48% | 288B | |
+7.22% | 92.67B | |
+25.88% | 89.12B | |
+66.58% | 62.08B | |
+13.31% | 45.82B | |
+19.47% | 35.53B | |
-15.40% | 30.2B | |
+17.47% | 29.72B |
- Stock Market
- Equities
- A089230 Stock
- News The E&M Co., Ltd.
- The E&M Co., Ltd. announced that it has received KRW 5 billion in funding from Hwail Pharmaceutical Co.,Ltd.